Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
Triclabendazole; Ivermectin
Elanco GmbH
QP54AA51
Triclabendazole; Ivermectin
50, 1 milligram(s)/millilitre
Oral suspension
POM: Prescription Only Medicine as defined in relevant national legislation
ivermectin, combinations
Authorised
2016-06-17
Health Products Regulatory Authority 05 April 2019 CRN008WV9 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Fasimec Duo 50 mg/ml + 1 mg/ml oral suspension for sheep 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE INGREDIENTS: Ivermectin 1 mg/ml Triclabendazole 50 mg/ml EXCIPIENTS: Methyl parahydroxybenzoate (E218) 1.4 mg/ml Propyl parahydroxybenzoate (E216) 0.5 mg/ml Benzyl alcohol 5.0 mg/ml For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension Cream coloured aqueous oral suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES For sheep over 3 months of age. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of mixed trematode (fluke) and nematode or arthropod infections due to gastrointestinal roundworms, lungworms, liver fluke and nasal bots. GASTROINTESTINAL NEMATODES (ADULT AND IMMATURE): _Haemonchus contortus, Teladorsagia (Ostertagia) circumcincta, Trichostrongylus spp, Cooperia spp, Nematodirus spp_ including _N._ _battus_, _Strongyloides papillosus, Oesophagostomum spp_, and adult _Chabertia ovina._ Inhibited larval stages and benzimidazole resistant strains of _Haemonchus contortus_ and _Teladorsagia (Ostertagia) circumcincta_ are also controlled. LIVER FLUKE (MATURE, IMMATURE AND EARLY IMMATURE STAGES DOWN TO LESS THAN 1 WEEK OF AGE): _Fasciola hepatica_ LUNGWORMS (ADULT AND IMMATURE): _Dictyocaulus filaria_ NASAL BOTS (ALL STAGES): _Oestrus ovis_ 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredients or any of the excipients. Health Products Regulatory Authority 05 April 2019 CRN008WV9 Page 2 of 5 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE I. SPECIAL PRECAUTIONS FOR USE IN ANIMALS Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: Too frequent and repeated use of anthelmintics from the same class, over an extended Lees het volledige document